Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 11, 2013 - Issue 11
Submit an article Journal homepage
360
Views
69
CrossRef citations to date
0
Altmetric
Reviews

Diagnosis and treatment of schistosomiasis in children in the era of intensified control

Stefanie KnoppDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, P.O. Box, CH–4002,Basel, Switzerland;University of Basel, P.O. Box, CH–4003,Basel, Switzerland;Department of Life Sciences, Natural History Museum, Cromwell Road, London, SW7 5BD,UKCorrespondence[email protected]
,
Sören L BeckerDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, P.O. Box, CH–4002,Basel, Switzerland;University of Basel, P.O. Box, CH–4003,Basel, Switzerland;Institute of Medical Microbiology and Hygiene, University of Saarland Hospital, D–66421,Homburg/Saar, Germany
,
Katrin J IngramUniversity of Basel, P.O. Box, CH–4003,Basel, Switzerland;Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, P.O. Box, CH–4002,Basel, Switzerland
,
Jennifer KeiserUniversity of Basel, P.O. Box, CH–4003,Basel, Switzerland;Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, P.O. Box, CH–4002,Basel, Switzerland
&
Jürg UtzingerDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, P.O. Box, CH–4002,Basel, Switzerland;University of Basel, P.O. Box, CH–4003,Basel, Switzerland
Pages 1237-1258 | Published online: 10 Jan 2014

References

  • King CH. Parasites and poverty: the case of schistosomiasis. Acta Trop. 113(2), 95–104 (2010).
  • Utzinger J, N’Goran EK, Caffrey CR, Keiser J. From innovation to application: social-ecological context, diagnostics, drugs and integrated control of schistosomiasis. Acta Trop. 120 (Suppl. 1), S121–S137 (2011).
  • Gryseels B. Schistosomiasis. Infect. Dis. Clin. North Am. 26(2), 383–397 (2012).
  • Murray CJL, Vos T, Lozano R et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859), 2197–2223 (2012).
  • WHO. Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases – A Roadmap for Implementation. World Health Organization, Geneva, Switzerland (2012).
  • WHO. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Tech. Rep. Ser. 912, 1–57 (2002).
  • WHO. Schistosomiasis: number of people treated in 2011. Wkly Epidemiol Rec 88, 81–88 (2013).
  • WHO. WHA65.21. Elimination of schistosomiasis. In: Sixty-Fifth World Health Assembly. Geneva 21–26 May 2012. Resolutions, Decisions and Annexes. World Health Organization, Geneva, Switzerland, 36–37 (2012).
  • Knopp S, Mohammed KA, Ali SM et al. Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach. BMC Public Health 12(1), 930 (2012).
  • Rollinson D, Knopp S, Levitz S et al. Time to set the agenda for schistosomiasis elimination. Acta Trop. doi:10.1016/j.actatropica.2012.04.013 (2013).
  • Fenwick A, Webster JP, Bosque-Oliva E et al. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002–2008. Parasitology 136(13), 1719–1730 (2009).
  • Utzinger J, Raso G, Brooker S et al. Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology 136(13), 1859–1874 (2009).
  • Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet 368(9541), 1106–1118 (2006).
  • Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. Dis. 6(7), 411–425 (2006).
  • Gray DJ, Ross AG, Li YS, McManus DP. Diagnosis and management of schistosomiasis.. BMJ 342, d2651 (2011).
  • Ross AG, Bartley PB, Sleigh AC et al. Schistosomiasis. N. Engl. J. Med. 346(16), 1212–1220 (2002).
  • Woolhouse MEJ. Patterns in parasite epidemiology: the peak shift. Parasitol. Today 14(10), 428–434 (1998).
  • Kabatereine NB, Vennervald BJ, Ouma JH et al. Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns. Parasitology 118(Pt 1), 101–105 (1999).
  • David JR, Butterworth AE. Immunity to schistosomes: advances and prospects. Ann. Intern. Med. 91(4), 641–643 (1979).
  • Capron A, Dessaint JP, Capron M, Ouma JH, Butterworth AE. Immunity to schistosomes: progress toward vaccine. Science 238(4830), 1065–1072 (1987).
  • Raso G, Vounatsou P, McManus DP, N’Goran EK, Utzinger J. A Bayesian approach to estimate the age-specific prevalence of Schistosoma mansoni and implications for schistosomiasis control. Int. J. Parasitol. 37(13), 1491–1500 (2007).
  • Karanja DM, Hightower AW, Colley DG et al. Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study. Lancet 360(9333), 592–596 (2002).
  • Knopp S, Person B, Ame SM et al. Elimination of schistosomiasis transmission in Zanzibar: baseline findings before the onset of a randomized intervention trial. PLoS Negl. Trop. Dis. 7, e2474 (2013).
  • Handzel T, Karanja DM, Addiss DG et al. Geographic distribution of schistosomiasis and soil-transmitted helminths in western Kenya: implications for anthelminthic mass treatment. Am. J. Trop. Med. Hyg. 69(3), 318–323 (2003).
  • Rudge JW, Stothard JR, Basáñez MG et al. Micro-epidemiology of urinary schistosomiasis in Zanzibar: local risk factors associated with distribution of infections among schoolchildren and relevance for control. Acta Trop. 105(1), 45–54 (2008).
  • Houmsou R, Kela S, Suleiman M, Ogidi J. Perceptions and assessment of risk factors in Schistosoma haematobium infection in Buruku and Katsina-Ala local government areas of Benue state - Nigeria. IJID 8(1), doi: 10.5580/5526fa (2010).
  • Lansdown R, Ledward A, Hall A et al. Schistosomiasis, helminth infection and health education in Tanzania: achieving behaviour change in primary schools. Health Educ. Res. 17(4), 425–433 (2002).
  • Mwanga JR, Lwambo NJS. Pre- and post-intervention perceptions and water contact behaviour related to schistosomiasis in north-western Tanzania. Acta Trop. doi:10.1016/j.actatropica.2012.09.017 (2013).
  • Kosinski KC, Crocker JJ, Durant JL, Osabutey D, Adjei MN, Gute DM. A novel community-based water recreation area for schistosomiasis control in rural Ghana. JWaSHDev 1(4), 259–268 (2011).
  • Kosinski KC, Adjei MN, Bosompem KM et al. Effective control of Schistosoma haematobium infection in a Ghanaian community following installation of a water recreation area. PLoS Negl. Trop. Dis. 6(7), e1709 (2012).
  • Ishii A, Tsuji M, Tada I. History of Katayama disease: schistosomiasis japonica in Katayama district, Hiroshima, Japan. Parasitol. Int. 52(4), 313–319 (2003).
  • Ross AG, Vickers D, Olds GR, Shah SM, McManus DP. Katayama syndrome. Lancet Infect. Dis. 7(3), 218–224 (2007).
  • Leshem E, Maor Y, Meltzer E, Assous M, Schwartz E. Acute schistosomiasis outbreak: clinical features and economic impact. Clin. Infect. Dis. 47(12), 1499–1506 (2008).
  • Jaureguiberry S, Paris L, Caumes E. Acute schistosomiasis, a diagnostic and therapeutic challenge. Clin. Microbiol. Infect. 16(3), 225–231 (2010).
  • Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol. Cell Biol. 85(2), 148–154 (2007).
  • King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365(9470), 1561–1569 (2005).
  • King CH, Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn. 4(1), 65–79 (2008).
  • van der Werf MJ, de Vlas SJ, Brooker S et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 86(2–3), 125–139 (2003).
  • Barsoum RS. Schistosomiasis and the kidney. Sem. Nephrol. 23(1), 34–41 (2003).
  • Ferrari TC, Moreira PR. Neuroschistosomiasis: clinical symptoms and pathogenesis. Lancet Neurol. 10(9), 853–864 (2011).
  • Vale TC, de Sousa-Pereira SR, Ribas JG, Lambertucci JR. Neuroschistosomiasis mansoni: literature review and guidelines. Neurologist 18(6), 333–342 (2012).
  • Jordan P, Webbe G. Human Schistosomiasis William Heinemann Medical Books Ltd, London, United Kingdom (1969).
  • Ekpo UF, Oluwole AS, Abe EM, Etta HE, Olamiju F, Mafiana CF. Schistosomiasis in infants and pre-school-aged children in sub-Saharan Africa: implication for control. Parasitology 139(7), 835–841 (2012).
  • Stothard JR, Sousa-Figueiredo JC, Betson M, Bustinduy A, Reinhard-Rupp J. Schistosomiasis in African infants and preschool children: let them now be treated! Trends Parasitol. 29(4), 197–205 (2013).
  • Secor WE. The effects of schistosomiasis on HIV/AIDS infection, progression and transmission. Curr. Opin. HIV AIDS 7(3), 254–259 (2012).
  • Ezeamama AE, McGarvey ST, Hogan J et al. Treatment for Schistosoma japonicum, reduction of intestinal parasite load, and cognitive test score improvements in school-aged children. PLoS Negl. Trop. Dis. 6(5), e1634 (2012).
  • Jia TW, Utzinger J, Deng Y et al. Quantifying quality of life and disability of patients with advanced schistosomiasis japonica. PLoS Negl. Trop. Dis. 5(2), e966 (2011).
  • Fürst T, Silué KD, Ouattara M et al. Schistosomiasis, soil-transmitted helminthiasis, and sociodemographic factors influence quality of life of adults in Côte d’Ivoire. PLoS Negl. Trop. Dis. 6(10), e1855 (2012).
  • Samuels AM, Matey E, Mwinzi PN et al. Schistosoma mansoni morbidity among school-aged children: a SCORE project in Kenya. Am. J. Trop. Med. Hyg. 87(5), 874–882 (2012).
  • Yap P, Fürst T, Müller I, Kriemler S, Utzinger J, Steinmann P. Determining soil-transmitted helminth infection status and physical fitness of school-aged children. J. Vis. Exp. (66), e3966 (2012).
  • Stothard JR, Sousa-Figueiredo JC, Betson M et al. Schistosoma mansoni infections in young children: when are schistosome antigens in urine, eggs in stool and antibodies to eggs first detectable? PLoS Negl. Trop. Dis. 5(1), e938 (2011).
  • Ekpo UF, Alabi OM, Oluwole AS, Sam-Wobo SO. Schistosoma haematobium infections in preschool children from two rural communities in Ijebu East, south-western Nigeria. J. Helminthol. 86(3), 323–328 (2012).
  • Coulibaly JT, N’Gbesso YK, N’Guessan NA, Winkler MS, Utzinger J, N’Goran EK. Epidemiology of schistosomiasis in two high-risk communities of south Côte d’Ivoire with particular emphasis on preschool-aged children. Am. J. Trop. Med. Hyg. 89(1), 32–41 (2013).
  • Garba A, Lamine MS, Djibo A et al. Safety and efficacy of praziquantel syrup (Epiquantel™) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger. Acta Trop. doi: 10.1016/j.actatropica.2012.12.003 (2013).
  • Becker SL, Vogt J, Knopp S et al. Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests. BMC Infect. Dis. 13, 37 (2013).
  • Yansouni CP, Bottieau E, Lutumba P et al. Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect. Dis. 13(6), 546–558 (2013).
  • Fenwick A, Savioli L, Engels D, Bergquist NR, Todd MH. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol. 19(11), 509–515 (2003).
  • Utzinger J, Keiser J. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin. Pharmacother. 5(2), 263–285 (2004).
  • Doenhoff MJ, Cioli D, Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21(6), 659–667 (2008).
  • WHO. Preventive Chemotherapy in Human Helminthiasis: Coordinated Use of Anthelminthic Drugs in Control Interventions: A Manual for Health Professionals and Programme Managers World Health Organization, Geneva, Switzerland (2006).
  • Stothard IR, Sousa-Figueiredo BC, Navaratnam AMD. Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis. Expert Rev. Anti. Infect. Ther. 11(7), 733–752 (2013).
  • Keiser J, Utzinger J. Advances in the discovery and development of trematocidal drugs. Expert Opin. Drugs Dis. 2(s1), 9–23 (2007).
  • Hall A, Nokes C, Wen ST et al. Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 93(6), 653–658 (1999).
  • Sousa-Figueiredo JC, Betson M, Stothard JR. Treatment of schistosomiasis in African infants and preschool-aged children: downward extension and biometric optimization of the current praziquantel dose pole. Int. Health 4(2), 95–102 (2012).
  • Danso-Appiah A, Utzinger J, Liu J, Olliaro P. Drugs for treating urinary schistosomiasis. Cochrane Database Syst. Rev. (3), CD000053 (2008).
  • Danso-Appiah A, Olliaro PL, Donegan S, Sinclair D, Utzinger J. Drugs for treating Schistosoma mansoni infection. Cochrane Database Syst. Rev. 2, CD000528 (2013).
  • Coulibaly JT, N’Gbesso YK, Knopp S, Keiser J, N’Goran EK, Utzinger J. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium. PLoS Negl. Trop. Dis. 6(12), e1917 (2012).
  • Sabah AA, Fletcher C, Webbe G, Doenhoff MJ. Schistosoma mansoni: chemotherapy of infections of different ages. Exp. Parasitol. 61(3), 294–303 (1986).
  • Talaat M, Miller FD. A mass chemotherapy trial of praziquantel on Schistosoma haematobium endemicity in Upper Egypt. Am. J. Trop. Med. Hyg. 59(4), 546–550 (1998).
  • Meyer T, Sekljic H, Fuchs S, Bothe H, Schollmeyer D, Miculka C . Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment. PLoS Negl. Trop. Dis 3(1), e357 (2009).
  • Navaratnam AM, Sousa-Figueiredo JC, Stothard JR, Kabatereine NB, Fenwick A, Mutumba-Nakalembe MJ. Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety. Trans. R. Soc. Trop. Med. Hyg. 106(7), 400–407 (2012).
  • WHO. Schistosomiasis: Progress Report 2001–2011 and Strategic Plan 2012–2020. World Health Organization, Geneva, Switzerland (2013).
  • Caffrey CR, Secor WE. Schistosomiasis: from drug deployment to drug development. Curr. Opin. Infect. Dis. 24(5), 410–417 (2011).
  • Botros SS, Bennett JL. Praziquantel resistance. Expert Opin. Drug Discov. 2(s1), S35–40 (2007).
  • Stelma FF, Talla I, Sow S et al. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 53(2), 167–170 (1995).
  • Danso-Appiah A, de Vlas SJ. Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends Parasitol. 18(3), 125–129 (2002).
  • Ismail M, Botros S, Metwally A et al. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 60(6), 932–935 (1999).
  • Utzinger J, Keiser J, Xiao SH, Tanner M, Singer BH. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob. Agents Chemother. 47(5), 1487–1495 (2003).
  • Nwaka S, Ridley RG. Virtual drug discovery and development for neglected diseases through public-private partnerships. Nat. Rev. Drug Discov. 2(11), 919–928 (2003).
  • Nwaka S, Hudson A. Innovative lead discovery strategies for tropical diseases. Nat. Rev. Drug Discov. 5(11), 941–955 (2006).
  • Keiser J, Utzinger J. Antimalarials in the treatment of schistosomiasis. Curr. Pharm. Des. 18(24), 3531–3538 (2012).
  • Utzinger J, Xiao SH, Tanner M, Keiser J. Artemisinins for schistosomiasis and beyond. Curr. Opin. Investig. Drugs 8(2), 105–116 (2007).
  • Liu R, Dong HF, Guo Y, Zhao QP, Jiang MS. Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis. Parasit. Vectors 4, 201 (2011).
  • Perez del Villar L, Burguillo FJ, Lopez-Aban J, Muro A. Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis. PLoS One 7(9), e45867 (2012).
  • De Clercq D, Vercruysse J, Verle P, Kongs A, Diop M. What is the effect of combining artesunate and praziquantel in the treatment of Schistosoma mansoni infections? Trop. Med. Int. Health 5(10), 744–746 (2000).
  • Utzinger J, N’Goran EK, N’Dri A, Lengeler C, Xiao SH, Tanner M. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 355(9212), 1320–1325 (2000).
  • Utzinger J, Chollet J, Tu Z, Xiao SH, Tanner M. Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice. Trans. R. Soc. Trop. Med. Hyg. 96(3), 318–323 (2002).
  • Keiser J, Chollet J, Xiao SH et al. Mefloquine – an aminoalcohol with promising antischistosomal properties in mice. PLoS Negl. Trop. Dis. 3(1), e350 (2009).
  • Keiser J, N’Guessan NA, Adoubryn KD et al. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clin. Infect. Dis. 50(9), 1205–1213 (2010). 1213 (2010).
  • Basra A, Mombo-Ngoma G, Melser MC et al. Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial. Clin. Infect. Dis. 56(6), e68–e75 (2013).
  • Keiser J, Ingram K, Utzinger J. Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control. Parasitology 138(12), 1620–1632 (2011).
  • White NJ, Nosten F, Looareesuwan S et al. Averting a malaria disaster. Lancet 353(9168), 1965–1967 (1999).
  • Sousa-Figueiredo JC, Betson M, Atuhaire A et al. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children. PLoS Negl. Trop. Dis. 6(10), e1864 (2012).
  • Castro N, Medina R, Sotelo J, Jung H. Bioavailability of praziquantel increases with concomitant administration of food. Antimicrob. Agents Chemother. 44(10), 2903–2904 (2000).
  • Njomo D, Tomono N, Muhoho N, Mitsui Y, Josyline K, Mwandawiro C. The adverse effects of albendazole and praziquantel in mass drug administration by trained schoolteachers. Afr. J. Health Sci. 17(3–4), 10–14 (2010).
  • Molyneux DH, Hotez PJ, Fenwick A. “Rapid-impact interventions”: how a policy of integrated control for Africa’s neglected tropical diseases could benefit the poor. PLoS Med. 2(11), e336 (2005).
  • Mbabazi WB, Nanyunja M, Makumbi I et al. Achieving measles control: lessons from the 2002–2006 measles control strategy for Uganda. Health Policy Plan. 24(4), 261–269 (2009).
  • Stevens ER, Aldridge A, Degbey Y, Pignandi A, Dorkenoo MA, Hugelen-Padin J. Evaluation of the 2011 long-lasting, insecticide-treated net distribution for universal coverage in Togo. Malar. J. 12, 162 (2013).
  • Mafe MA, Appelt B, Adewale B et al. Effectiveness of different approaches to mass delivery of praziquantel among school-aged children in rural communities in Nigeria. Acta Trop. 93(2), 181–190 (2005).
  • Muhumuza S, Olsen A, Katahoire A, Nuwaha F. Uptake of preventive treatment for intestinal schistosomiasis among school children in Jinja district, Uganda: a cross- sectional study. PLoS One 8(5), e63438 (2013).
  • Massa K, Olsen A, Sheshe A, Ntakamulenga R, Ndawi B, Magnussen P. Can coverage of schistosomiasis and soil transmitted helminthiasis control programmes targeting school-aged children be improved? New approaches. Parasitology 136(13), 1781–1788 (2009).
  • Magnussen P, Vennervald BJ, Aagaard-Hansen J. Schistosomiasis. In: Water and Sanitation Related Diseases and the Environment: Challenges, Interventions and Preventive Measures. Selendy JMH (Ed.). Wiley-Blackwell, Hoboken, New Jersey, United States of America 167–174 (2011).
  • Parker M, Allen T. Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda. Health Res. Policy Syst. 9, 3 (2011).
  • N’Goran EK, Utzinger J, N’Guessan AN et al. Reinfection with Schistosoma haematobium following school-based chemotherapy with praziquantel in four highly endemic villages in Côte d’Ivoire. Trop. Med. Int. Health 6(10), 817–825 (2001).
  • Augusto G, Magnussen P, Kristensen TK, Appleton CC, Vennervald BJ. The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique. Parasitology 136(13), 1771–1779 (2009).
  • King CH, Olbrych SK, Soon M, Singer ME, Carter J, Colley DG. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. PLoS Negl. Trop. Dis. 5(9), e1321 (2011).
  • Sturrock RF. Schistosomiasis: complimentary snail control in chemotherapeutic based control programmes. In: Parasitic Diseases: Treatment and Control. Miller MJ, Love ES (Eds). CRC Press, Baton Rouge, USA, 51–60 (1989).
  • Sturrock RF. Current concepts of snail control. Mem. Inst. Oswaldo Cruz 90(2), 241–248 (1995).
  • Kariuki HC, Madsen H, Ouma JH et al. Long term study on the effect of mollusciciding with niclosamide in stream habitats on the transmission of schistosomiasis mansoni after community-based chemotherapy in Makueni district, Kenya. Parasit. Vectors 6(1), 107 (2013).
  • WHO. The Role of Mollusciciding in Schistosomiasis Control. World Health Organization, Geneva, Switzerland (1983).
  • McCullough FS. The Role of Mollusciciding in Schistosomiasis Control. World Health Organization, Geneva, Switzerland (1992).
  • WHO. The control of schistosomiasis. WHO Tech. Rep. Ser. 830, 1–86 (1993).
  • Laamrani H, Khallaayoune K, Madsen H, Mahjour J, Gryseels B. New challenges in schistosomiasis control in Morocco. Acta Trop. 77(1), 61–67 (2000).
  • Laamrani H, Mahjour J, Madsen H, Khallaayoune K, Gryseels B. Schistosoma haematobium in Morocco: moving from control to elimination. Parasitol. Today 16(6), 257–260 (2000).
  • World Bank. Project Performance Assessment Report. Arab Republic of Egypt. National Schistosomiasis Control Project (Credit no. 2403-EGT). World Bank, Washington DC, USA (2008).
  • Yang GJ, Li W, Sun LP et al. Molluscicidal efficacies of different formulations of niclosamide: result of meta-analysis of Chinese literature. Parasit. Vectors 3, 84 (2010).
  • McCullough FS. Biological control of the snail intermediate hosts of human Schistosoma spp.: a review of its present status and future prospects. Acta Trop. 38(1), 5–13 (1981).
  • Pointier JP. Invading freshwater snails and biological control in Martinique Island, French West Indies. Mem. Inst. Oswaldo Cruz 96 Suppl, 67–74 (2001).
  • Utzinger J, Bergquist R, Xiao SH, Singer BH, Tanner M. Sustainable schistosomiasis control – the way forward. Lancet 362(9399), 1932–1934 (2003).
  • Singer BH, Castro MC. Bridges to sustainable tropical health. Proc. Natl Acad. Sci. USA 104, 16038–16043 (2007).
  • Gray DJ, McManus DP, Li Y, Williams GM, Bergquist R, Ross AG. Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect. Dis. 10(10), 733–736 (733).
  • Freeman MC, Ogden S, Jacobson J et al. Integration of water, sanitation, and hygiene for the prevention and control of neglected tropical diseases: a rationale for inter-sectoral collaboration. PLoS Negl. Trop. Dis. 7, e2439 (2013).
  • Sow S, Polman K, Vereecken K, Vercruysse J, Gryseels B, de Vlas SJ. The role of hygienic bathing after defecation in the transmission of Schistosoma mansoni. Trans. R. Soc. Trop. Med. Hyg. 102(6), 542–547 (2008).
  • Soares Magalhães RJ, Barnett AG, Clements ACA. Geographical analysis of the role of water supply and sanitation in the risk of helminth infections of children in West Africa. Proc. Natl. Acad. Sci. USA 108(50), 20084–20089 (2011).
  • Abou-Zeid AH, Abkar TA, Mohamed RO. Schistosomiasis and soil-transmitted helminths among an adult population in a war affected area, Southern Kordofan state, Sudan. Parasit. Vectors 5, 133 (2012).
  • Knopp S, Stothard JR, Rollinson D et al. From morbidity control to transmission control: time to change tactics against helminths on Unguja Island, Zanzibar. Acta Trop. doi:10.1016/j.actatropica.2011.04.010 (2013) (Epub ahead of print).
  • Esrey SA, Potash JB, Roberts L, Shiff C. Effects of improved water supply and sanitation on ascariasis, diarrhoea, dracunculiasis, hookworm infection, schistosomiasis, and trachoma. Bull. World Health Organ. 69(5), 609–621 (1991).
  • Tchuem Tchuenté LA, Southgate VR, Webster BL, De Bont J, Vercruysse J. Impact of installation of a water pump on schistosomiasis transmission in a focus in Cameroon. Trans. R. Soc. Trop. Med. Hyg. 95(3), 255–256 (2001).
  • McManus DP, Loukas A. Current status of vaccines for schistosomiasis. Clin. Microbiol. Rev. 21(1), 225–242 (2008).
  • Bergquist NR, Colley DG. Schistosomiasis vaccine: research to development. Parasitol. Today 14(3), 99–104 (1998).
  • Loukas A, Tran M, Pearson MS. Schistosome membrane proteins as vaccines. Int. J. Parasitol. 37(3–4), 257–263 (2007).
  • Bickle QD. Radiation-attenuated schistosome vaccination–a brief historical perspective. Parasitology 136(12), 1621–1632 (2009).
  • Lin D, Tian F, Wu H et al. Multiple vaccinations with UV-attenuated cercariae in pig enhance protective immunity against Schistosoma japonicum infection as compared to single vaccination. Parasit. Vectors 4, 103 (2011).
  • Capron A, Riveau G, Capron M, Trottein F. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol. 21(3), 143–149 (2005).
  • Tendler M, Simpson AJ. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine. Acta Trop. 108(2–3), 263–266 (2008).
  • Webster JP, Oliviera G, Rollinson D, Gower CM. Schistosome genomes: a wealth of information. Trends Parasitol. 26(3), 103–106 (2010).
  • Lochmatter C, Schneider CL, Ingram K, Keiser J, Schifferli JA. Schistosoma mansoni tetraspanning orphan receptor (SmTOR): a new vaccine candidate against schistosomiasis. Clin. Exp. Immunol. 170(3), 342–357 (2012).
  • Riveau G, Deplanque D, Remoue F et al. Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis. PLoS Negl. Trop. Dis. 6(7), e1704 (2012).
  • Berriman M, Haas BJ, LoVerde PT et al. The genome of the blood fluke Schistosoma mansoni. Nature 460(7253), 352–358 (2009).
  • The Schistosoma japonicum genome sequencing and functional analysis consortium. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 460(7253), 345–351 (2009).
  • Young ND, Jex AR, Li B et al. Whole-genome sequence of Schistosoma haematobium. Nat. Genet. 44(2), 221–225 (2012).
  • Zerlotini A, Aguiar ER, Yu F et al. SchistoDB: an updated genome resource for the three key schistosomes of humans. Nucleic Acids Res. 41(Database issue), D728–D731v (2013).
  • WHO. Food, Water and Family Health: A Manual for Community Educators. WHO/HEP/94.2 World Health Organization, Geneva, Switzerland (1994).
  • Wang LD, Chen HG, Guo JG et al. A strategy to control transmission of Schistosoma japonicum in China. N. Engl. J. Med. 360(2), 121–128 (2009).
  • Utzinger J, Zhou XN, Chen MG, Bergquist R. Conquering schistosomiasis in China: the long march. Acta Trop. 96(2–3), 69–96 (2005).
  • Zhou XN, Bergquist R, Leonardo L et al. Schistosomiasis japonica: control and research needs. Adv. Parasitol. 72, 145–178 (2010).
  • Chitsulo L, Lengeler C, Jenkins J. The Schistosomiasis Manual: A Guide for the Rapid Identification of Communities with a High Prevalence of Urinary Schistosomiasis for District Health Management Teams. World Health Organization, Geneva, Switzerland (1995).
  • Lengeler C, Utzinger J, Tanner M. Questionnaires for rapid screening of schistosomiasis in sub-Saharan Africa. Bull. World Health Organ. 80(3), 235–242 (2002).
  • The Red Urine Study Group. Identification of High-Risk Communities for Schistosomiasis in Africa: A Multicountry Study. World Health Organization, Geneva, Switzerland (1995).
  • Lengeler C, Makwala J, Ngimbi D, Utzinger J. Simple school questionnaires can map both Schistosoma mansoni and Schistosoma haematobium in the Democratic Republic of Congo. Acta Trop. 74(1), 77–87 (2000).
  • Savioli L, Hatz C, Dixon H, Kisumku UM, Mott KE. Control of morbidity due to Schistosoma haematobium on Pemba Island: egg excretion and hematuria as indicators of infection. Am. J. Trop. Med. Hyg. 43(3), 289–295 (1990).
  • Brooker S, Kabatereine NB, Gyapong JO, Stothard JR, Utzinger J. Rapid mapping of schistosomiasis and other neglected tropical diseases in the context of integrated control programmes in Africa. Parasitology 136(13), 1707–1718 (1707).
  • Stete K, Krauth SJ, Coulibaly JT et al. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children. Parasit. Vectors 5, 298 (2012).
  • Colley DG, Binder S, Campbell C et al. A five-country evaluation of a point-of-care circulating cathodic antigen urine assay for the prevalence of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 88(3), 426–432 (2013).
  • Coulibaly JT, Knopp S, N’Guessan NA et al. Accuracy of urine circulating cathodic antigen (CCA) test for Schistosoma mansoni diagnosis in different settings of Côte d’Ivoire. PLoS Negl. Trop. Dis. 5(11), e1384 (2011).
  • Standley C, Lwambo NJS, Lange C, Kariuki H, Adriko M, Stothard J. Performance of circulating cathodic antigen (CCA) urine-dipsticks for rapid detection of intestinal schistosomiasis in schoolchildren from shoreline communities of Lake Victoria. Parasit. Vectors 3(1), 7 (2010).
  • Hotez PJ, Bundy DAP, Beegle K et al. Helminth infections: soil-transmitted helminth infections and schistosomiasis. In: Disease Control Priorities in Developing Countries. Jamison DT, Breman JG, Measham AR et al. (Eds), The World Bank Group, Washington, District of Columbia, United States of America 467–482 (2006).
  • Peters PA, Mahmoud AA, Warren KS, Ouma JH, Siongok TK. Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples. Bull. World Health Organ. 54(2), 159–162 (1976).
  • Montresor A, Crompton DWT, Hall A, Bundy DAP, Savioli L. Guidelines for the Evaluation of Soil-Transmitted Helminthiasis and Schistosomiasis at Community Level. World Health Organization, Geneva, Switzerland (1998).
  • Danso-Appiah A, Garner P, Olliaro PL, Utzinger J. Treatment of urinary schistosomiasis: methodological issues and research needs identified through a Cochrane systematic review. Parasitology 136(13), 1837–1849 (2009).
  • Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev. Inst. Med. Trop. São Paulo 14(6), 397–400 (1972).
  • Booth M, Vounatsou P, N’Goran EK, Tanner M, Utzinger J. The influence of sampling effort and the performance of the Kato-Katz technique in diagnosing Schistosoma mansoni and hookworm co-infections in rural Côte d’Ivoire. Parasitology 127, 525–531 (2003).
  • Lin DD, Liu JX, Liu YM et al. Routine Kato-Katz technique underestimates the prevalence of Schistosoma japonicum: a case study in an endemic area of the People’s Republic of China. Parasitol. Int. 57(3), 281–286 (2008).
  • Cringoli G, Rinaldi L, Maurelli MP, Utzinger J. FLOTAC: new multivalent techniques for qualitative and quantitative copromicroscopic diagnosis of parasites in animals and humans. Nat. Protoc. 5, 503–515 (2010).
  • Glinz D, Silué KD, Knopp S et al. Comparing diagnostic accuracy of Kato-Katz, Koga agar plate, ether-concentration, and FLOTAC for Schistosoma mansoni and soil-transmitted helminths. PLoS Negl. Trop. Dis. 4, e754 (2010).
  • Knopp S, Speich B, Hattendorf J et al. Diagnostic accuracy of Kato-Katz and FLOTAC for assessing anthelmintic drug efficacy. PLoS Negl. Trop. Dis. 5(4), e1036 (2011).
  • Albonico M, Rinaldi L, Sciascia S et al. Comparison of three copromicroscopic methods to assess albendazole efficacy against soil-transmitted helminth infections in school-aged children on Pemba Island. Trans. R. Soc. Trop. Med. Hyg. 107(8), 493–501 (2013).
  • Enk MJ, Oliveira e Silva G, Rodrigues NB. Diagnostic accuracy and applicability of a PCR system for the detection of Schistosoma mansoni DNA in human urine samples from an endemic area. PLoS One 7(6), e38947 (2012).
  • ten Hove RJ, Verweij JJ, Vereecken K, Polman K, Dieye L, van Lieshout L. Multiplex real-time PCR for the detection and quantification of Schistosoma mansoni and S. haematobium infection in stool samples collected in northern Senegal. Trans. R. Soc. Trop. Med. Hyg. 102(2), 179–185 (2008).
  • Aryeetey YA, Essien-Baidoo S, Larbi IA et al. Molecular diagnosis of Schistosoma infections in urine samples of school children in Ghana. Am. J. Trop. Med. Hyg. 88(6), 1028–1031 (2013).
  • Pontes LA, Dias-Neto E, Rabello A. Detection by polymerase chain reaction of Schistosoma mansoni DNA in human serum and feces. Am. J. Trop. Med. Hyg. 66(2), 157–162 (2002).
  • Wichmann D, Panning M, Quack T et al. Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma. PLoS Negl. Trop. Dis. 3(4), e422 (2009).
  • Enk MJ, Oliveira ESG, Rodrigues NB. A salting out and resin procedure for extracting Schistosoma mansoni DNA from human urine samples. BMC Res. Notes 3, 115 (2010).
  • Ibironke OA, Phillips AE, Garba A, Lamine SM, Shiff C. Diagnosis of Schistosoma haematobium by detection of specific DNA fragments from filtered urine samples. Am. J. Trop. Med. Hyg. 84(6), 998–1001 (2011).
  • Xu J, Rong R, Zhang HQ, Shi CJ, Zhu XQ, Xia CM. Sensitive and rapid detection of Schistosoma japonicum DNA by loop-mediated isothermal amplification (LAMP). Int. J. Parasitol. 40(3), 327–331 (2010).
  • Abbasi I, King CH, Muchiri EM, Hamburger J. Detection of Schistosoma mansoni and Schistosoma haematobium DNA by loop-mediated isothermal amplification: identification of infected snails from early prepatency. Am. J. Trop. Med. Hyg. 83(2), 427–432 (2010).
  • Hamburger J, Abbasi I, Kariuki C et al. Evaluation of loop-mediated isothermal amplification suitable for molecular monitoring of schistosome-infected snails in field laboratories. Am. J. Trop. Med. Hyg. 88(2), 344–351 (2013).
  • Zhu YC. Immunodiagnosis and its role in schistosomiasis control in China: a review. Acta Trop. 96(2–3), 130–136 (2005).
  • Steinmann P, Zhou XN, Matthys B et al. Spatial risk profiling of Schistosoma japonicum in Eryuan county, Yunnan province, China. Geospat. Health 2(1), 59–73 (2007).
  • Zhou YB, Liang S, Jiang QW. Factors impacting on progress towards elimination of transmission of schistosomiasis japonica in China. Parasit. Vectors 5, 275 (2012).
  • Corstjens PL, van Lieshout L, Zuiderwijk M et al. Up-converting phosphor technology-based lateral flow assay for detection of Schistosoma circulating anodic antigen in serum. J. Clin. Microbiol. 46(1), 171–176 (2008).
  • Downs JA, van Dam GJ, Changalucha JM et al. Association of schistosomiasis and HIV infection in Tanzania. Am. J. Trop. Med. Hyg. 87(5), 868–873 (2012).
  • Dönges J. [The miracidia hatching test in bilharziasis]. Ger. Med. Mon. 12(3), 116–117 (1967).
  • Jurberg AD, Oliveira AA, Lenzi HL, Coelho PM. A new miracidia hatching device for diagnosing schistosomiasis. Mem. Inst. Oswaldo Cruz 103(1), 112–114 (2008).
  • Coelho PM, Jurberg AD, Oliveira AA, Katz N. Use of a saline gradient for the diagnosis of schistosomiasis. Mem. Inst. Oswaldo Cruz 104(5), 720–723 (2009).
  • Barda B, Zepherine H, Rinaldi L et al. Mini-FLOTAC and Kato-Katz: helminth eggs watching on the shore of Lake Victoria. Parasit. Vectors 6(1), 220 (2013).
  • Cringoli G, Rinaldi L, Albonico M, Bergquist R, Utzinger J. Geospatial (s)tools: integration of advanced epidemiological sampling and novel diagnostics. Geospat. Health 7(2), 399–404 (2013).
  • Sheele JM, Kihara JH, Baddorf S, Byrne J, Ravi B. Evaluation of a novel rapid diagnostic test for Schistosoma haematobium based on the detection of human immunoglobulins bound to filtered Schistosoma haematobium eggs. Trop. Med. Int. Health 18(4), 477–484 (2013).
  • Smith H, Doenhoff M, Aitken C et al. Comparison of Schistosoma mansoni soluble cercarial antigens and soluble egg antigens for serodiagnosing schistosome infections. PLoS Negl. Trop. Dis. 6(9) (2012).
  • Coulibaly JT, N’Goran EK, Utzinger J, Doenhoff MJ, Dawson EM. A new rapid diagnostic test for detection of anti-Schistosoma mansoni and anti-Schistosoma haematobium antibodies. Parasit. Vectors 6, 29 (2013).
  • Dawson E, Sousa-Figueiredo JC, Kabatereine N, Doenhoff M, Stothard JR. Intestinal schistosomiasis in pre school-aged children of Lake Albert, Uganda: diagnostic accuracy of a rapid test for detection of anti-schistosome antibodies. Trans. R. Soc. Trop. Med. Hyg. 107(10), 639–647 (2013)
  • Bogoch II, Andrews JR, Speich B et al. Mobile phone microscopy for the diagnosis of soil-transmitted helminth infections: a proof-of-concept study. Am. J. Trop. Med. Hyg. 88(4), 626–629 (2013).
  • Pai NP, Vadnais C, Denkinger C, Engel N, Pai M. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med. 9(9), e1001306 (2012).
  • Mekonnen Z, Meka S, Ayana M, Bogers J, Vercruysse J, Levecke B. Comparison of individual and pooled stool samples for the assessment of soil-transmitted helminth infection intensity and drug efficacy. PLoS Negl. Trop. Dis. 7(5), e2189 (2013).
  • Bergquist R, Johansen MV, Utzinger J. Diagnostic dilemmas in helminthology: what tools to use and when? Trends Parasitol. 25(4), 151–156 (151).
  • Visser LG, Polderman AM, Stuiver PC. Outbreak of schistosomiasis among travelers returning from Mali, West Africa. Clin. Infect. Dis. 20(2), 280–285 (1995).
  • Black CL, Mwinzi PN, Muok EM et al. Influence of exposure history on the immunology and development of resistance to human schistosomiasis mansoni. PLoS Negl. Trop. Dis. 4(3), e637 (2010).
  • Johansen MV, Sithithaworn P, Bergquist R, Utzinger J. Towards improved diagnosis of zoonotic trematode infections in Southeast Asia. Adv. Parasitol. 73, 171–195 (2010).
  • McCarthy JS, Lustigman S, Yang GJ et al. A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl. Trop. Dis. 6(4), e1601 (2012).
  • Enk MJ, Lima AC, Massara CL, Coelho PM, Schall VT. A combined strategy to improve the control of Schistosoma mansoni in areas of low prevalence in Brazil. Am. J. Trop. Med. Hyg. 78(1), 140–146 (2008).
  • Knopp S, Mgeni AF, Khamis IS et al. Diagnosis of soil-transmitted helminths in the era of preventive chemotherapy: effect of multiple stool sampling and use of different diagnostic techniques. PLoS Negl. Trop. Dis. 2(11), e331 (2008).
  • Berger A. Th1 and Th2 responses: what are they? BMJ 321(7258), 424 (2000).
  • Secor WE, Sundstrom JB. Below the belt: new insights into potential complications of HIV-1/schistosome coinfections. Curr. Opin. Infect. Dis. 20(5), 519–523 (2007).
  • Mbabazi PS, Andan O, Fitzgerald DW, Chitsulo L, Engels D, Downs JA. Examining the relationship between urogenital schistosomiasis and HIV infection. PLoS Negl. Trop. Dis. 5(12), e1396 (2011).
  • Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am. J. Trop. Med. Hyg. 49(4), 440–447 (1993).
  • Göbel T, Erhardt A, Richter J, Poremba C, Haussinger D. Chronic hepatitis B with an unexpected coinfection. Med. Klin. (Munich) 105(11), 827–830 (2010).
  • Abdel-Rahman M, El-Sayed M, El Raziky M et al. Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response. World J. Gastroenterol. 19(17), 2691–2696 (2013).
  • Chen L, Liu WQ, Lei JH et al. Chronic Schistosoma japonicum infection reduces immune response to vaccine against hepatitis B in mice. PLoS ONE 7(12), e51512 (2012).
  • Range N, Magnussen P, Mugomela A et al. HIV and parasitic co-infections in tuberculosis patients: a cross-sectional study in Mwanza, Tanzania. Ann. Trop. Med. Parasitol. 101(4), 343–351 (2007).
  • Li XX, Zhou XN. Co-infection of tuberculosis and parasitic diseases in humans: a systematic review. Parasit. Vectors 6, 79 (2013).
  • Barnhill AE, Novozhilova E, Day TA, Carlson SA. Schistosoma-associated Salmonella resist antibiotics via specific fimbrial attachments to the flatworm. Parasit. Vectors 4, 123 (2011).
  • Gendrel D, Kombila M, Beaudoin-Leblevec G, Richard-Lenoble D. Nontyphoidal salmonellal septicemia in Gabonese children infected with Schistosoma intercalatum. Clin. Infect. Dis. 18(1), 103–105 (1994).
  • Druilhe P, Tall A, Sokhna C. Worms can worsen malaria: towards a new means to roll back malaria? Trends Parasitol. 21(8), 359–362 (2005).
  • Florey LS, King CH, Van Dyke MK et al. Partnering parasites: evidence of synergism between heavy Schistosoma haematobium and Plasmodium species infections in Kenyan children. PLoS Negl. Trop. Dis. 6(7), e1723 (2012).
  • Briand V, Watier L, le Hesran JY, Garcia A, Cot M. Coinfection with Plasmodium falciparum and Schistosoma haematobium: protective effect of schistosomiasis on malaria in Senegalese children? Am. J. Trop. Med. Hyg. 72(6), 702–707 (2005).
  • Wilson RA. Virulence factors of schistosomes. Microbes. Infect. 14(15), 1442–1450 (2012).
  • Keiser J, N’Goran EK, Singer BH, Lengeler C, Tanner M, Utzinger J. Association between Schistosoma mansoni and hookworm infections among schoolchildren in Côte d’Ivoire. Acta Trop. 84(1), 31–41 (2002).
  • Raso G, Vounatsou P, Gosoniu L, Tanner M, N’Goran EK, Utzinger J. Risk factors and spatial patterns of hookworm infection among schoolchildren in a rural area of western Côte d’Ivoire. Int. J. Parasitol. 36(2), 201–210 (2006).
  • Ezeamama AE, Friedman JF, Olveda RM et al. Functional significance of low-intensity polyparasite helminth infections in anemia. J. Infect. Dis. 192(12), 2160–2170 (2005).
  • Tzanetou K, Tsiodra P, Delis V et al. Coinfection of Schistosoma mansoni and Strongyloides stercoralis in a patient with variceal bleeding. Infection 33(4), 292–294 (2005).
  • Fairweather M, Burt BM, VanderLaan PA, Brunker PA, Bafford AC, Ashley SW. Acute hemorrhage from small bowel diverticula harboring strongyloidiasis and schistosomiasis. Am. Surg. 76(5), 539–541 (2010).
  • Abruzzi A, Fried B. Coinfection of Schistosoma (Trematoda) with bacteria, protozoa and helminths. Adv. Parasitol. 77, 1–85 (2011).
  • van Hellemond JJ, Vonk AG, de Vogel C et al. Association of eumycetoma and schistosomiasis. PLoS Negl. Trop. Dis. 7(5), e2241 (2013).
  • Hunter JM, Rey L, Chu KY, Adekolu-John EO, Mott KE. Parasitic Diseases in Water Resources Development: The Need for Intersectoral Collaboration. Organization, WH), World Health Organization, Geneva, Switzerland (1993).
  • UN. A New Global Partnership: Eradicate Poverty and Transform Economies Through Sustainable Development. The Report of the High-Level Panel of Eminent Persons on the Post-2015 Development Agenda. United Nations, New York, USA (2013).
  • Fenwick A, Keiser J, Utzinger J. Epidemiology, burden and control of schistosomiasis with particular consideration to past and current treatments trends. Drugs Future 31(5), 413–425 (2006).
  • WHO. Sustaining the Drive to Overcome the Global Impact of Neglected Tropical Diseases. Second WHO Report on Neglected Tropical Diseases. World Health Organization, Geneva, Switzerland (2013).
  • De Clercq D, Vercruysse J, Verle P, Niasse F, Kongs A, Diop M. Efficacy of artesunate against Schistosoma mansoni infections in Richard Toll, Senegal. Trans. R. Soc. Trop. Med. Hyg. 94(1), 90–91 (2000).
  • Marti H, Escher E. [SAF - an alternative fixation solution for parasitological stool specimens]. Schweiz. Med. Wochenschr. 120, 1473–1476 (1990). [in German]
  • WHO. Bench Aids for the Diagnosis of Intestinal Parasites. World Health Organization, Geneva, Switzerland (1994).
  • Zhu Y, He W, Liang Y et al. Development of a rapid, simple dipstick dye immunoassay for schistosomiasis diagnosis. J. Immunol. Methods 266(1–2), 1–5 (2002).
  • Lier T, Simonsen GS, Wang T et al. Real-time polymerase chain reaction for detection of low-intensity Schistosoma japonicum infections in China. Am. J. Trop. Med. Hyg. 81(3), 428–432 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.